ABUS vs ENPH · P/E 5.4, rev $6.2M vs P/E 56, rev $1.47B
Arbutus Biopharma Corp (ABUS) versus Enphase Energy Inc (ENPH) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Enphase Energy Inc (ENPH) is a solar company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported ENPH revenue for 2025-12-31 was $1.47B. Net income was $172.1M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
Not investment advice. Open the ABUS and ENPH stock pages for the full models.
Not investment advice.